Key stats
About GLOBAL X GENOMICSBIOTECH
Expense ratio
0.50%
Home page
Inception date
Nov 2, 2021
ISIN
IE00BM8R0N95
The Funds investment objective is to generate returns that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region
Displays a symbol's price movements over previous years to identify recurring trends.